Every year, malaria afflicts hundreds of millions of people and kills hundreds of thousands of children. Despite considerable success in reducing the worldwide prevalence of malaria, its incidence in visitors to endemic areas has continued to rise steadily.
Currently, the best available prevention of malaria requires oral dosing of antimalarial tablets. Chronic oral dosing of these medicines has significant complications because healthy people need to strictly adhere to the medication in order for effective prophylaxis to occur.
A new study, published in Nature Communications highlights a new 'long acting' medicine for the prevention of malaria.
The study aimed to utilize nanotechnology to improve the delivery of an existing antimalarial drug via a novel injectable format that can maintain blood concentration of the drug for weeks or months following a single dose.
Solid Drug Nanoparticles (SDNs) are a nanotechnology with favorable characteristics to enhance drug exposure and improve the treatment or prevention of several diseases, including HIV and malaria.
The team have previously shown SDNs to be effective for oral delivery of drugs, but this is the first time they have shown benefits for a long-acting injectable (LAI) format. These particles have an approximate diameter that is 1/500th the width of a human hair, and once injected into the muscle, establish a drug depot that releases drug into the bloodstream over an extended period of time.
Through the use of this technology the team developed an LAI version of a daily anti-malarial tablet (atovaquone) which provided prophylactic blood concentrations in mice for a period of 28 days. Moreover, mice injected with the nanomedicine were completely protected from the malaria parasite when exposed during this time, and since mice eliminate the drug much more rapidly in humans, a much longer duration of protection might be expected in people.
https://news.liverpool.ac.uk/2018/01/22/new-long-acting-approach-malaria-therapy-developed/
https://www.nature.com/articles/s41467-017-02603-z
Latest News
Novel mechanism for regulating the reward behavior
High through-put technique to screen gene expression in multiple cells for drug discovery!
Predicting people's age by measuring proteins in blood
Changes in human brain exposed to extreme antarctic conditions
c-Jun overexpression to prevent CAR-T cells exhaustion
Other Top Stories
Treating colon cancer with vitamin A
Hypomethylation of smoking-related genes is associated with future lung cancer
Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts
Communication between tumor cells and the endothelium through nanoscale membrane bridges for microRNA transfer
Alternate pathway to inhibit tumor suppressor P53 in cancer
Protocols
Dual-Angle Protocol for Doppler Optical Coherence Tomography to Improve Retinal Blood Flow Measur…
Detection of protein SUMOylation in vivo
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induce…
Determination of SUMOylation sites
miR-Selection 3'UTR Target Selection Kit
Publications
Phosphorylation of Npas4 by MAPK Regulates Reward-Related Gene Expression and Behaviors
Phosphorylation of Npas4 by MAPK Regulates Reward-Related Gene Expression and Behaviors
Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts
Quantitative In Vivo Proteomics of Metformin Response in Liver Reveals AMPK-Dependent and -Indepe…
Quantitative In Vivo Proteomics of Metformin Response in Liver Reveals AMPK-Dependent and -Indepe…
Presentations
Hypoxia Inducible Factor - 1 (HIF-1)
Intracellular Protein Degradation
Pathophysiology of Type 1 Diabetes
Plant Viruses
Regulation by changes in chromatin structure
Posters
AACC-2018-Infectious Disease
AACC-2018-Mass Spectrometry Applications
AACC-2018-Lipids/Lipoproteins
AACC-2018-Management
AACC-2018-Immunology-abstracts